iTeos Therapeutics, Inc.
ITOS
$10.13
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 515.43M | 520.37M | 494.65M | 488.71M | 571.26M |
| Total Receivables | 2.55M | 3.27M | 3.69M | 42.80M | 42.35M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 11.02M | 13.41M | 11.20M | 13.36M | 13.00M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 528.99M | 537.05M | 509.54M | 544.88M | 626.61M |
|
|
|||||
| Total Current Assets | 528.99M | 537.05M | 509.54M | 544.88M | 626.61M |
| Net Property, Plant & Equipment | 10.30M | 10.10M | 9.98M | 10.89M | 10.83M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9.17M | 7.81M | 7.10M | 7.12M | 6.56M |
| Total Assets | 623.08M | 658.87M | 686.98M | 723.08M | 751.84M |
|
|
|||||
| Total Accounts Payable | 6.25M | 14.00M | 8.50M | 7.15M | 11.06M |
| Total Accrued Expenses | 61.03M | 21.05M | 29.12M | 26.86M | 20.73M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.52M | 1.41M | 1.34M | 1.35M | 1.28M |
| Total Finance Division Other Current Liabilities | 1.48M | 1.54M | 1.40M | 1.45M | 1.60M |
| Total Other Current Liabilities | 1.48M | 1.54M | 1.40M | 1.45M | 1.60M |
| Total Current Liabilities | 70.27M | 38.00M | 40.36M | 36.81M | 34.67M |
|
|
|||||
| Total Current Liabilities | 70.27M | 38.00M | 40.36M | 36.81M | 34.67M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.61M | 3.64M | 3.76M | 4.17M | 4.24M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 55.40M | 53.81M | 52.56M | 50.40M | 49.07M |
| Total Liabilities | 129.28M | 95.45M | 96.68M | 91.39M | 87.97M |
|
|
|||||
| Common Stock & APIC | 633.11M | 622.74M | 616.07M | 608.73M | 601.14M |
| Retained Earnings | -123.12M | -44.39M | -9.78M | 33.93M | 79.29M |
| Treasury Stock & Other | -16.19M | -14.92M | -16.00M | -10.97M | -16.56M |
| Total Common Equity | 493.80M | 563.42M | 590.29M | 631.69M | 663.87M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 493.80M | 563.42M | 590.29M | 631.69M | 663.87M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 493.80M | 563.42M | 590.29M | 631.69M | 663.87M |
|
|
|||||